RNAC Financing Cash Flow
Cartesian Therapeutics Inc · Financing Cash Flow
RNAC Financing Cash Flow
Latest reported$50.25Mperiod ending
RNAC TTM Cash from Financing ($43.91M → $50.25M)
TTM financing cash flow
High-resolution chart · PNG
RNAC financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 50,254,000 | |
| 15,641,000 | |
| -8,055,000 | |
| -7,220,000 | |
| 117,312,000 | |
| 117,372,000 | |
| 168,428,000 | |
| 181,726,000 | |
| 32,443,000 | |
| 29,737,000 | |
| -13,145,000 | |
| -27,226,000 | |
| -1,825,000 | |
| 37,636,000 | |
| 39,215,000 | |
| 60,371,000 | |
| 61,209,000 | |
| 33,318,000 | |
| 52,897,000 | |
| 31,551,000 | |
| 51,049,000 | |
| 41,108,000 | |
| 14,431,000 | |
| 83,155,000 | |
| 67,235,000 | |
| 68,564,000 | |
| 105,041,000 | |
| 36,587,000 | |
| 31,814,000 | |
| 31,753,000 | |
| 697,000 | |
| 5,655,000 | |
| 12,731,000 | |
| 66,366,000 | |
| 66,023,000 | |
| 63,777,000 | |
| 58,805,000 | |
| 69,044,000 | |
| 67,659,000 | |
| 70,553,000 | |
| 100,179,000 | |
| 42,436,000 | |
| 43,906,000 |